Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin.

Puerarin is a major isoflavonoid compound isolated from Pueraria lobata, an edible vine used widely for various medicinal purposes. It has been used for centuries in China to counteract alcohol intoxication. However, the effects of puerarin on chemical-induced liver fibrosis have not been reported. In the present study, we investigated the effects of puerarin on liver fibrosis in Wistar rats induced by alcohol plus carbon tetrachloride administration. Liver fibrosis was produced in rats by treatment with a mixture (50% alcohol, 8 g/kg per day; corn oil, 2 g/kg per day; pyrazole, 24 mg/kg per day; ig) once a day and by intraperitoneal injection of 0.25 ml/kg of a 25% solution of carbon tetrachloride in olive oil twice a week for 8 weeks. After 8 weeks, treatment with puerarin (0.4 and 0.8 g/kg ig, daily for 4 weeks) was conducted to examine its therapeutic effects. At the same time, the model group and treatment group continued to receive the chemical mixture, while the control group received saline instead of the chemical mixture. Upon pathological examination, the puerarin-treated rats significantly reversed the symptoms of liver fibrosis and other hepatic lesions. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), as indexes of hepatic cell disruption, were reduced with puerarin treatment, whereas no significant effect was discovered in the levels of alkaline phosphatase (ALP) and gamma-glutamyltransferase (GGT) activities. A significant increase in apoptosis of activated hepatic stellate cell (HSC) was found by flow cytometric analysis of the hepatic tissues. And the expression of bcl-2 mRNA was down-regulated after puerarin administration. Consequently, all these results showed that puerarin could effectively reverse chemical-induced liver fibrosis in experimental rats, via the recovery of hepatic injury as well as the induction of apoptosis in activated HSC.

[1]  K. Ishak,et al.  Histological grading and staging of chronic hepatitis. , 1995 .

[2]  G. Cantelli-forti,et al.  Comparison between chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP-catalysed drug metabolism. , 2000, Life sciences.

[3]  T. Y. Wang,et al.  Effects of puerarin against glutamate excitotoxicity on cultured mouse cerebral cortical neurons. , 1998, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[4]  J. Iredale,et al.  Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. , 1998, The Journal of clinical investigation.

[5]  Roger Williams,et al.  Drugs and the liver part 1: Testing liver function , 1991, Biopharmaceutics & drug disposition.

[6]  A. Hara,et al.  Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin. , 1996, Cancer research.

[7]  M. Uysal,et al.  Betaine or taurine administration prevents fibrosis and lipid peroxidation induced by rat liver by ethanol plus carbon tetrachloride intoxication , 2004, Amino Acids.

[8]  T. Cleveland,et al.  Evaluation of the estrogenic effects of legume extracts containing phytoestrogens. , 2003, Journal of agricultural and food chemistry.

[9]  S. Friedman.  Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury* , 2000, The Journal of Biological Chemistry.

[10]  Young-suk Kim,et al.  Hepatoprotective activity of reduohanxiao-tang (yuldahanso-tang) is related to the inhibition of beta-glucuronidase. , 2003, The American journal of Chinese medicine.

[11]  F. Hsu,et al.  Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. , 2003, Journal of natural products.

[12]  J. Iredale,et al.  Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors , 2001, Gut.

[13]  C. Lieber.  Prevention and treatment of liver fibrosis based on pathogenesis. , 1999, Alcoholism, clinical and experimental research.

[14]  N. Namasivayam,et al.  Activity of Cassia auriculata leaf extract in rats with alcoholic liver injury. , 2003, The Journal of nutritional biochemistry.

[15]  G. Macdonald.  Pathogenesis of hepatocellular carcinoma. , 2001, Clinics in liver disease.

[16]  Huiling He,et al.  Maintenance of Calcium Homeostasis in the Endoplasmic Reticulum by Bcl-2 , 1997, The Journal of cell biology.

[17]  K. Bhoola,et al.  Natural products for cancer prevention: a global perspective. , 2003, Pharmacology & therapeutics.

[18]  W. Chang,et al.  Inhibitory effects of flavonoids on xanthine oxidase. , 1993, Anticancer research.

[19]  S. Krane,et al.  Mutation in collagen‐I that confers resistance to the action of collagenase results in failure of recovery from CCl4‐induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  P. Norton,et al.  Animal models of liver fibrosis. , 1996, Scandinavian journal of gastroenterology.

[21]  S. Sherlock.  [Drugs and the liver]. , 1968, Giornale di clinica medica.

[22]  P. Scheuer,et al.  Classification of chronic viral hepatitis: a need for reassessment. , 1991, Journal of hepatology.

[23]  W. Keung.  Biochemical studies of a new class of alcohol dehydrogenase inhibitors from Radix puerariae. , 1993, Alcoholism, clinical and experimental research.

[24]  L. Kirshenbaum,et al.  The bcl-2 gene product prevents programmed cell death of ventricular myocytes. , 1997, Circulation.

[25]  G. Chiou,et al.  Improvement of ocular blood flow and retinal functions with puerarin analogs. , 1999, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.